Cronos is the first offering targeted at financial firms from ClearSight, which has until now targeted telecom providers, carriers and companies with large network infrastructures that are critical to ...
IRVINE, CA, – Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) ...
CA-based global leader in the science of heart valves and hemodynamic monitoring – Edwards Lifesciences Corporation (EW) – has received the U.S. Food and Drug Administration (:FDA) approval for its ...